Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY)
Annals of Transplantation · 2025
DOI: 10.12659/aot.949241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Transplantation, 2025. Verfasst von Sang-Hoon Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor with poor prognosis. This retrospective study aimed to evaluate the outcomes and prognostic factors of 40 patients who underwent liver transplantation (LT) for cHCC-CC using data from the Korean Organ Transplant Registry (KOTRY). MATERIAL AND METHODS A cohort of 40 LT recipients diagnosed with cHCC-CC was selected from the KOTRY database between 2014 and 2019. Survival analyses were performed according to key clinicopathological variables, and risk factor analyses were conducted for overall survival (OS) and recurrence-free survival (RFS). RESULTS During a median follow-up of 21.4 months, 10 patients (25.0%) died and 9 patients (22.5%) experienced tumor recurrence. The 1-, 2-, and 3-year OS rates were 91.8%, 76.2%, and 59.3%, respectively, and the corresponding RFS rates were 88.8%, 70.5%, and 50.2%. Patients with a MELD score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Department of Liver Transplantation and Hepatobiliary Surgery, Ajou University School of Medicine, Suwon, South Korea.
- Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Surgery, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Pusan, South Korea.
Zitieren
APA
Kim, S. H., Hwang, S., Kim, B. W., Joo, D. J., Lee, K. W., Choi, G. S., Ryu, J. H., Kim, D. S., Choi, D., Cho, J. Y., You, Y. K., Choi, D., Kim, T. S., & Park, P. (2025). Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY). Annals of Transplantation. https://doi.org/10.12659/aot.949241
Vancouver
Kim SH, Hwang S, Kim BW, Joo DJ, Lee KW, Choi GS, et al. Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY). Annals of Transplantation. 2025. doi:10.12659/aot.949241
BibTeX
@article{Kim2025,
author = {Kim, Sang-Hoon and Hwang, Shin and Kim, Bong-Wan and Joo, Dong Jin and Lee, Kwang-Woong and Choi, Gyu-Seong and Ryu, Je Ho and Kim, Dong-Sik and Choi, Dongho and Cho, Jai Young and You, Young Kyoung and Choi, Dongho and Kim, Tae-Seok and Park, PyoungJae},
title = {Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY)},
journal = {Annals of Transplantation},
year = {2025},
doi = {10.12659/aot.949241}
}
EUVIMED